Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia
March 2000
The FDA just approved Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia.
This is the first antibiotic to be approved for this use.
Strep pneumoniae is the most common cause of community-acquired pneumonia. It used to be very sensitive to penicillin...but now resistance is growing.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote